Register for this webinar entitled - Cytokines and Receptors in Cancer Immunotherapy
Cytokines are a key area of interest in cancer immunotherapy. Interleukin (IL)-2, IL-4, IL-7, IL-9, IL-15, and IL-21 comprise a cytokine family based on sharing a receptor component, the common cytokine receptor γ chain (γc). γc family cytokines generally activate three major signaling pathways (PI3K-Akt, RAS-MAPK, and JAK-STAT) to regulate the development, survival, proliferation, differentiation, and function of cells in both the innate and adaptive immune systems. Recently, designer cytokines for γc family have shown significant therapeutic potential in cancer, allergy, immunodeficiency, and autoimmunity. This webinar will discuss the critical biological roles and therapeutic applications of γc cytokines and receptors.
Watch a preview below.
Cytokines in Cancer Therapy
- General overview of cytokines
- Introduction to the common gamma chain cytokine family
- Role of common gamma chain cytokines in cancer immunotherapy
- Future developments of common gamma chain cytokines in cancer immunotherapy
About the speaker:
Sylvia Xie is a Product Scientist at Sino Biological US Inc., a manufacturer of high-quality research reagents, where she manages the product catalog and supports product development. Prior to joining Sino Biological, Sylvia received her M.S. degree from the University of Houston in Biomedical Engineering, where her research focused on targeted drug therapy in autoimmune diseases.
Who should attend:
Researchers studying cancer; Researchers studying immunotherapy; Pharmaceutical companies developing cancer drugs;